http://www.news-medical.net/news/20140325/Study-suggests-that-self-administration-of-influenza-vaccine-may-be-feasible-with-microneedle-patch.aspx
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment